Prothena Corp Analyst Ratings
Buy Rating Affirmed for Prothena Amid Strong Pipeline Prospects and Strategic Partnerships
Prothena (PRTA) Receives a Buy From Piper Sandler
Analysts' Opinions Are Mixed on These Healthcare Stocks: Teleflex (TFX), Bioxcel Therapeutics (BTAI) and Prothena (PRTA)
Buy Rating Affirmed for Prothena Amid Strong Pipeline and Financial Health
Prothena Corp Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Paragon 28 (FNA), Prothena (PRTA)
Prothena Corp Analyst Ratings
Prothena Corp Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Belite Bio, Inc. ADR (BLTE) and Prothena (PRTA)
Piper Sandler Reaffirms Their Buy Rating on Prothena (PRTA)
Oppenheimer Cuts Prothena Price Target to $80 From $98, Maintains Outperform Rating
Buy Rating Affirmed on Prothena Amid Strong Pipeline Progress and Solid Financials
Prothena Corp Analyst Ratings
RBC Trims Price Target on Prothena to $35 From $36, Keeps Sector Perform, Speculative Risk
RBC Capital Reaffirms Their Hold Rating on Prothena (PRTA)
Promising Outlook for Prothena's Amyloidosis Treatments: Analyst Endorses Buy Rating
Prothena Corp Analyst Ratings
Prothena Corp Analyst Ratings
RBC Cuts Price Target on Prothena to $36 From $43, Calls Initial Data on PRX012 'Anticlimactic,' Keeps Sector Perform, Speculative Risk